MLchartDataset catalogue

IND

Term · Oncology and biomedicine · MLC-T-ONC-004269

A substance that has been tested in the laboratory and has been approved by the U.S. Food and Drug Administration (FDA) for testing in people. Clinical trials test how well INDs work and whether they are safe to use. An IND may be approved by the FDA for use in one disease or condition but still be considered investigational in other diseases or conditions. Also called experimental drug, investigational agent, investigational drug, and investigational new drug.

Table 1. Record
IdentifierMLC-T-ONC-004269
FieldOncology and biomedicine
Expansionsexperimental drug; investigational agent; investigational drug; investigational new drug
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004269",
  "term": "IND",
  "field": "Oncology and biomedicine",
  "definition": "A substance that has been tested in the laboratory and has been approved by the U.S. Food and Drug Administration (FDA) for testing in people. Clinical trials test how well INDs work and whether they are safe to use. An IND may be approved by the FDA for use in one disease or condition but still be considered investigational in other diseases or conditions. Also called experimental drug, investigational agent, investigational drug, and investigational new drug.",
  "expansions": [
    "experimental drug",
    "investigational agent",
    "investigational drug",
    "investigational new drug"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ind/"
}

Record 9,163 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.